Search

Author/Creator Salgado, R.

34. Tumor infiltrating lymphocytes in patients receiving trastuzumab/pertuzumab-based chemotherapy: A TRYPHAENA substudy. (April 2018)

Authors:
Ignatiadis, M.; Van den Eynden, G.; Salgado, R.; Fornili, M.; Bareche, Y.; Desmedt, C.; Rothé, F.; Maetens, M.; David, V.; Holgado, E.; McNally, V.; Kiermaier, A.; Savage, H.M.; Wilson, T.R.; Cortes, J.; Schneeweiss, A.; Willard-Gallo, K.; Biganzoli, E.; Sotiriou, C.
Journal:
European journal of cancer
Issue:
Volume 92(2018)Supplement 3
Page Start:
S15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials. (June 2017)

Authors:
Solinas, C.; Ceppi, M.; Lambertini, M.; Scartozzi, M.; Buisseret, L.; Garaud, S.; Fumagalli, D.; de Azambuja, E.; Salgado, R.; Sotiriou, C.; Willard-Gallo, K.; Ignatiadis, M.
Journal:
Cancer treatment reviews
Issue:
Volume 57(2017)
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗